Rhythm Pharmaceuticals Inc (RYTM)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

222 BERKELEY STREET BOSTON, MA 02116

Rhythm Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company specializes in the development of molecule therapies targeting metabolic pathways for the treatment of obesity, diabetes, and gastrointestinal functional disorders. Rhythm Pharmaceuticals serves patients in the United States.

Data as of 2020-11-22
Market Cap944.655 Million Shares Outstanding44.205 Million Avg 30-day Volume215.926 Thousand
P/E Ratio-7.1 Dividend Yield EPS-2.99
Price/Sales Price cash flow ratio Price free cash flow ratio-7.5
Book Value4.46 Price to Tangible Book4.8 Alpha-0.0
Short Interest Ratio % Short Interest to Float R-squared0.163994
BETA1.27991 52-week High/Low32.24 / 12.99 Stddev0.162879
View SEC Filings from RYTM instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 2 0.0% 1 (0.07%) 1 (0.06%) 0.0%
Funds Holding: 113 91 24.18% 28 (1.84%) 24 (1.56%) 16.67%
13F shares: 39.048 Million 41.008 Million -4.78% 15.903 Million 17.346 Million -8.32%
% Ownership 88.5075 92.9488 -4.78% 36.0453 39.316 -8.32%
New Positions: 31 21 47.62% 9 6 50.0%
Increased Positions 25 38 -34.21% 6 10 -40.0%
Closed Positions 9 10 -10.0% 5 4 25.0%
Reduced Positions 37 18 105.56% 11 6 83.33%
Total Calls 41.537 Thousand 100 41437.0% 20.2 Thousand
Total Puts 87.103 Thousand 0 28 Thousand
PUT/CALL Ratio 2.1 0.0 1.39
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RYTM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RYTM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CHIEN JENNIFER EVP, HEAD OF NORTH AMERICA

  • Officer
0 2020-11-09 2

MAZABRAUD YANN EVP, HEAD OF INTERNATIONAL

  • Officer
0 2020-10-05 2

DESIKAN NITHYA CHIEF COMMERCIAL OFFICER

  • Officer
43,602 2020-08-31 5

SMITH HUNTER C CHIEF FINANCIAL OFFICER

  • Officer
0 2020-07-20 6

MEEKER DAVID P PRESIDENT AND CEO

  • Officer
  • Director
0 2020-07-20 2

KELNER SIMON CHIEF HUMAN RESOURCES OFFICER

  • Officer
0 2020-06-30 2

STEWART MURRAY CHIEF MEDICAL OFFICER

  • Officer
0 2020-06-30 2

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
5,140,408 2020-06-30 1

FOLEY TODD

  • Director
1,909,258 2020-06-26 18

JEAN CHRISTOPHE

  • Director
0 2020-06-17 1

MCGIRR DAVID W J

  • Director
0 2020-06-17 1

MATHERS EDWARD T

  • Director
0 2020-06-17 1

GOOD JENNIFER L

  • Director
0 2020-06-17 1

ARBUCKLE STUART A

  • Director
0 2020-06-17 1

GOTTESDIENER KEITH MICHAEL CEO & PRESIDENT

  • Officer
  • Director
558,250 2020-03-09 3

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • 10% Owner
5,422,312 2019-10-16 0

VAN DER PLOEG LEONARDUS H.T. CHIEF SCIENTIFIC OFFICER

  • Officer
42,339 2019-05-30 0

THIRD ROCK VENTURES LP

THIRD ROCK VENTURES GP, L.P.

TRV GP, LLC

STARR KEVIN P

TEPPER ROBERT I

LEVIN MARK J

  • 10% Owner
3,278,752 2018-08-30 0

EXTER NEIL

  • Director
0 2018-06-06 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP V LLC

  • 10% Owner
  • SEE REMARKSSEE REMARKS
No longer subject to file 2018-05-22 0

FIEDOREK FRED T. CHIEF MEDICAL OFFICER

  • Officer
0 2018-02-14 0

MPM BIOVENTURES V, L.P.

EVNIN LUKE

GADICKE ANSBERT

MPM ASSET MANAGEMENT INVESTORS BV5 LLC

MPM BIOVENTURES V GP LLC

MPM BIOVENTURES V LLC

  • 10% Owner
2,696,392 2017-10-10 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP V LLC

ISALY SAMUEL D

  • 10% Owner
2,901,295 2017-10-10 0

IPSEN, S.A.

  • 10% Owner
No longer subject to file 2017-10-10 0

PFIZER INC

  • 10% Owner
No longer subject to file 2017-10-10 0

HADLEY HARBOR MASTER INVESTORS (CAYMAN) L.P.

  • 10% Owner
No longer subject to file 2017-10-10 0

BARRIS PETER J

  • 10% Owner
4,909,956 2017-10-10 0

BARRETT M JAMES

  • 10% Owner
4,909,956 2017-10-10 0

MOTT DAVID M

  • 10% Owner
4,909,956 2017-10-10 0

KERINS PATRICK J

  • 10% Owner
4,909,956 2017-10-10 0

BASKETT FOREST

  • 10% Owner
4,909,956 2017-10-10 0

VISWANATHAN RAVI

  • 10% Owner
4,909,956 2017-10-10 0

SANDELL SCOTT D

  • 10% Owner
4,909,956 2017-10-10 0

NEW ENTERPRISE ASSOCIATES 13 LP

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

  • 10% Owner
4,909,956 2017-10-10 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2017-10-10 0

BAKER BROS. ADVISORS LP

BAKER BROS. ADVISORS (GP) LLC

BAKER FELIX

BAKER JULIAN

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2017-10-05 0

SILVERSTEIN JONATHAN

  • Director
  • 10% Owner
0 2017-10-04 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CHIEN JENNIFER - Officer EVP, HEAD OF NORTH AMERICA

2020-11-10 16:07:20 -0500 2020-11-09 A 100,000 a 100,000 direct

MAZABRAUD YANN - Officer EVP, HEAD OF INTERNATIONAL

2020-10-06 16:10:44 -0400 2020-10-05 A 100,000 a 100,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments